TOPOISOMERASE-I INHIBITORS FOR UPPER GASTROINTESTINAL TRACT CARCINOMA

拓扑异构酶-I 抑制剂治疗上胃肠道癌

• 批准号: 3741488
• 负责人: HOWARD HOCHSTER
• 金额: --
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3741488
• 关键词: DNA topoisomerases; antineoplastics; clinical trials; drug screening /evaluation; enzyme inhibitors; esophagus neoplasm; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; stomach neoplasms

In this study, patients with esophageal or gastric cancer will be treated with topoisomerase-1 inhibitory compounds and the relevant tumor parameters that may predict tumor response to therapy will be investigated.

在这项研究中，食管癌或胃癌患者将接受治疗 拓扑异构酶-1抑制化合物和相关肿瘤 可以预测肿瘤对治疗的反应的参数将是 调查了。